BioSpace News Archive

Blade Therapeutics today announced that Wendye Robbins, M.D., President and Chief Executive Officer, will present at the 2020 Stifel Virtual Healthcare Conference. The virtual session will take place on Monday, November 16, 2020, at 3:20 – 3:50 p.m. Eastern Time. A link to the live and archived webcast presentation can be accessed on the “News & Events” page of the Blade company website at https://www.bla

Almirall, S.A. the global biopharmaceutical company based in Barcelona, has announced the nomination of Carlos Gallardo as Vice President of the Board of Directors effective immediately.

First randomized clinical trial demonstrating that CTC count may help personalize treatment choices

Centogene N.V. and Fujirebio Europe announced to have entered a partnership to leverage LUMIPULSE® G technology for large-scale COVID-19 antigen testing with further deployment in German airports.

SyntheticMR welcomes Dr Alex Rovira to their Medical Advisory Board to support their company with clinical expertise

Strengthening immunotherapies is especially critical for older adults with weakened immune systems

Dr. Johnson Brings More Than 25 Years of Experience in Developing and Implementing Global Regulatory and Clinical Development Strategies from Preclinical Through Product Approval

Kodiak Sciences Inc., a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, reported business highlights and financial results for the third quarter ended September 30, 2020.

Presented additional data from XMT-1536 Phase 1 study at ESMO demonstrating compelling and consistent activity and tolerability profile in ovarian cancer

Proceeds support advancement of lead gene therapy programs and accelerate development of therapeutics to restore functional hair cells in the inner ear